Regular users of NSAIDS such as ibuprofen were half as likely to develop the disease. For those who had used NSAIDS for more than two years, the risk of developing the disease dropped to 44%.
But the Parkinson’s Disease Society has dismissed the findings. Dr Kieran Breen, the society's director of research and development, said: ‘The research study does not establish that over the counter medications such as aspirin and non-aspirin non-steroidal anti-inflammatory drugs (NSAIDs) prevent Parkinson’s. Rather, it suggests that inflammation may play some kind of role in Parkinson’s.
'The research was not designed to establish a causal link between the use of over the counter medication and Parkinson’s.
'Other research studies, using greater numbers of people, have investigated the potential association of taking non-steroidal anti-inflammatory drugs and the risk of developing Parkinson’s, but could not find a link.'
Neurology (2007) 69:1836-1842